MIRT

August 27, 2014

UAMS Myeloma Institute Director Gareth Morgan, M.D., Ph.D., Named ARA Scholar

Ben Boulden

Aug. 27, 2014 | Gareth Morgan, M.D., Ph.D., director of the University of Arkansas  for Medical Sciences (UAMS) Myeloma Institute for Research and Therapy, was named an Arkansas Research Alliance (ARA) Scholar at a news conference today at the State Capitol.

April 22, 2014

Internationally Known Multiple Myeloma Expert Gareth Morgan, M.D., Ph.D., Coming to Lead UAMS Myeloma Institute

Ben Boulden

April 22, 2014 | World-renowned multiple myeloma researcher and clinician Gareth Morgan, M.D., Ph.D., today was named director of the University of Arkansas for Medical Sciences (UAMS) Myeloma Institute for Research and Therapy (MIRT).

December 7, 2011

UAMS Myeloma Institute Names Ammon to Lead Advisory Board

David Robinson

LITTLE ROCK – Carol A. Ammon, of Wilmington, Del., founder and retired chief executive officer and chairman of Endo Pharmaceuticals Inc., has been named chairman of the advisory board for the Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences (UAMS). <br />
<br />

November 9, 2011

UAMS Myeloma Institute Treats 10,000th Patient

Nate Hinkel

LITTLE ROCK – The internationally known Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences (UAMS) marked another milestone today, treatment of the 10,000th patient in its 22-year history.

June 9, 2011

Myeloma Clinical Trial Uses Natural Killer Cells

David Robinson

June 10, 2011 | A clinical trial on a first-of-its-kind treatment for multiple myeloma is now under way at the UAMS Myeloma Institute for Research and Therapy, using supercharged immune cells known as natural killer cells to attack cancer cells.